Get to Know Us
Welcome to the "Let's Fight AIDS Together" awareness initiative by Emcure Pharmaceuticals. Our mission is to empower you with the knowledge about HIV/AIDS which needed to make informed decisions about your health and well-being.
-
Emcure entered into HIV arena in year 2004 but soon established itself as a leader in HIV care by partnering with Innovators to bring novel molecules to Indian patients.
-
Emcure was the first in India to launch novel molecule Atazanavir in year 2006, this therapy changed the face of HIV treatment in India.
-
Emcure is preferred partner of Innovators including Abbvie, Bristol Myers-Squibb, Gilead, Medicines Patent Pool, ViiV.
-
Emcure is 1st in India to bring WHO recommended Dolutegravir based combinations.
-
Emcure has launched many Molecules and Fixed Dose combination for the 1st time in India.
-
Today Emcure is supplying anti-retroviral drugs to over 70+ countries in world.
-
We are committed to bring newer regimens with the collaboration with Innovators to our Indian patients and to the rest of the world in future.
-
Emcure is always in forefront for public awareness and social activities related to HIV therapy in association with NGOs like Network of positive people with HIV (NMP+) and Treatment, Adherence, Advocacy and Literacy (TAAL) Pharmacy.
-
Emcure conducts multiple Continuous Medical Education (CME) activities as well as Webinars to update the medical fraternities on HIV prevention, diagnosis, management, HIV related Opportunistic Infections, and newer formulations etc.
-
Occasional public awareness programs conducted by Emcure helping normal people to keep themselves safe from HIV and to reduce stigma & discrimination in the society.